Therapeutic MicroRNA Strategies in Human Cancer
نویسندگان
چکیده
منابع مشابه
Therapeutic strategies against cancer stem cells in human colorectal cancer
Colorectal cancer (CRC) is the third most frequent malignancy and represents the fourth most common cause of cancer-associated mortalities in the world. Despite many advances in the treatment of CRC, the 5-year survival rate of patients with CRC remains unsatisfactory due to tumor recurrence and metastases. Recently, cancer stem cells (CSCs), have been suggested to be responsible for the initia...
متن کاملmicroRNA-34a as a Therapeutic Agent against Human Cancer
microRNAs (miRNAs) are small non-coding RNAs that down-regulate expression of various target genes. Cancer-related miRNAs are aberrantly expressed and act as tumor suppressors or oncogenes during carcinogenesis. We and other researchers have demonstrated that important tumor suppressor miRNAs are silenced by epigenetic alterations, resulting in the activation of target oncogenes in cancer cells...
متن کاملTherapeutic Strategies in Ovarian Cancer
Therapeutic management for ovarian cancer (OC) requires effective treatment methods such as optimization in terms of technical variability, dosage, or administration period and the introduction of new therapeutic methods in the existing protocols, all in order to improve immediate results, especially of the long term. Establishing therapeutic strategies are based on the main factors that influe...
متن کاملTherapeutic strategies in colonic cancer.
Colonic cancer is the most common malignancy of the digestive tract, representing 13% of all malignancies. The aim of the study is to evaluate the current therapeutic strategy in patients with CC. Mortality from the disease is declining in many Western countries; this may be the result of screening for CC, resection of adenomas, early detection of tumoral lesions and the use of individualized t...
متن کاملMicroRNA Targeted Therapeutic Approach for Pancreatic Cancer
Pancreatic cancer remains the fourth leading cause of cancer-related death in the US and is expected to be the second leading cause of cancer-related death by 2030. Therefore, it is important to better understand the molecular pathogenesis, phenotypes and features of pancreatic cancer in order to design novel molecularly targeted therapies for achieving better therapeutic outcome of patients wi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The AAPS Journal
سال: 2009
ISSN: 1550-7416
DOI: 10.1208/s12248-009-9145-9